CCR9/CXCR5 Co-Expressing CD4 T Cells Are Increased in Primary Sjögren's Syndrome and Are Enriched in PD-1/ICOS-Expressing Effector T Cells.

Hinrichs, Anneline C; Kruize, Aike A; Lafeber, Floris P J G; Leavis, Helen L; van Roon, Joel A G

Hinrichs, Anneline C; Kruize, Aike A; Lafeber, Floris P J G; Leavis, Helen L; van Roon, Joel A G.

Afiliação

Hinrichs AC; Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, 3508 Utrecht, The Netherlands.
Kruize AA; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, 3508 Utrecht, The Netherlands.
Lafeber FPJG; Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, 3508 Utrecht, The Netherlands.
Leavis HL; Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, 3508 Utrecht, The Netherlands.
van Roon JAG; Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, 3508 Utrecht, The Netherlands.

Int J Mol Sci ; 24(15)2023 Jul 26.

Article em En | MEDLINE | ID: mdl-37569326

Assuntos

Linfócitos T CD4-Positivos; Síndrome de Sjogren; Humanos; Proteína Coestimuladora de Linfócitos T Induzíveis/metabolismo; Interleucinas/metabolismo; Leucócitos Mononucleares; Receptor de Morte Celular Programada 1/genética; Receptor de Morte Celular Programada 1/metabolismo; Receptores CXCR5/metabolismo; Linfócitos T Auxiliares-Indutores

Palavras-chave

CXCR5/CCR9 T cells; ICOS; PD-1; Sjögren's syndrome (pSS); Tfh; Tph

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T CD4-Positivos / Síndrome de Sjogren Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google